Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CSX vs MRNA✓SelectedUSD · MRNACSX vs MRNA performance historyLatest closeAs of+0.37%11/18
Stock and ETF performance explorer

CSX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+51.7%
MRNA return
-20.0%
Excess return
+71.7%
Maximum drawdown
-29.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.4%-4.8%+5.2%+0.5%
7D-1.1%-20.9%+19.8%-0.5%
30D+7.2%-13.3%+20.5%+7.4%
3M+2.4%+212.6%-210.1%-3.7%
6M+11.7%+309.0%-297.3%+2.3%
YTD+42.9%+567.3%-524.4%+25.0%
1Y+53.0%+689.7%-636.7%+31.8%
3Y+69.3%+157.4%-88.1%+53.4%
5Y+51.7%-21.7%+73.4%+40.5%
All+51.7%-20.0%+71.7%+40.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling